Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (Clinichip HPV™)

Journal of Virological Methods

Volumn 188, Issue 1-2, 2013, Pages 83-93

  Satoh, Toyomi ^a   Matsumoto, Koji ^a   Fujii, Takuma ^b   Sato, Osamu ^c   Gemma, Nobuhiro ^d   Onuki, Mamiko ^a   Saito, Hiroshi ^e   Aoki, Daisuke ^b   Hirai, Yasuo ^f   Yoshikawa, Hiroyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Sekisui Medical ^*  (Japan)

^d TOSHIBA CORPORATION   (Japan)

^e NATIONAL CANCER CENTER   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; HPV; HPV genotyping; Loop mediated isothermal amplification

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATION; BIOCHIP; CARCINOGENICITY; CLINICHIP HPV TEST; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; AUTOMATION, LABORATORY; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84872196153     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.10.014     Document Type: Article

References (25)

1. Bauer H.M., Ting Y., Greer C.E., Chambers J.C., Tashiro C.J., Chimera J., Reingold A., Manos M.M. Genital human papillomavirus infection in female university students as determined by a PCR-based method. J. Am. Med. Assoc. 1991, 265:472-477.
2. Castle P.E. The potential utility of HPV genotyping in screening and clinical management. J. Natl. Compr. Cancer Netw. 2008, 6:83-95.
3. Castle P.E., Rodríguez A.C., Burk R.D., Herrero R., Wacholder S., Alfaro M., Morales J., Guillen D., Sherman M.E., Solomon D., Schiffman M. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. Br. Med. J. 2009, 339:b2569. Proyecto Epidemiológico Guanacaste (PEG) Group.
4. Chen H.C., Schiffman M., Lin C.Y., Pan M.H., You S.L., Chuang L.C., Hsieh C.Y., Liaw K.L., Hsing A.W., Chen C.J. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J. Natl. Cancer Inst. 2011, 103:1387-1396. for the CBCSP-HPV Study Group.
5. Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D., McGoogan E., Menon U., Terry G., Edwards R., Brooks C., Desai M., Gie C., Ho L., Jacobs I., Pickles C., Sasieni P. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003, 362(9399):1871-1876.
6. Cuzick J., Clavel C., Petry K.U., Meijer C.J., Hoyer H., Ratnam S., Szarewski A., Birembaut P., Kulasingam S., Sasieni P., Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer 2006, 119:1095-1101.
7. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlée F., Hildesheim A., Schiffman M.H., Scott D.R., Apple R.J. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 2000, 38:357-361.
8. Hagiwara M., Sasaki H., Matsuo K., Honda M., Kawase M., Nakagawa H. Loop-mediated isothermal amplification method for detection of human papillomavirus type 6, 11, 16, and 18. J. Med. Virol. 2007, 79:605-615.
9. Jacobs M.V., Snijders P.J., van den Brule A.J., Helmerhorst T.J., Meijer C.J., Walboomers J.M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 1997, 35:791-7915.
10. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R., Rush B.B., Glass A.G., Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J. Natl. Cancer Inst. 2005, 97:1072-1079.
11. Kjaer S., Høgdall E., Frederiksen K., Munk C., van den Brule A., Svare E., Meijer C., Lorincz A., Iftner T. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res. 2006, 66:10630-10636.
12. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., ter Harmsel B., Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 1998, 153:1731-1739.
13. Luo L., Nie K., Yang M.J., Wang M., Li J., Zhang C., Liu H.T., Ma X.J. Visual detection of high-risk human papillomavirus genotypes 16, 18, 45, 52, and 58 by loop-mediated isothermal amplification with hydroxynaphthol blue dye. J. Clin. Microbiol. 2011, 49:3545-3550.
14. Matsumoto K., Oki A., Furuta R., Maeda H., Yasugi T., Takatsuka N., Mitsuhashi A., Fujii T., Hirai Y., Iwasaka T., Yaegashi N., Watanabe Y., Nagai Y., Kitagawa T., Yoshikawa H. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int. J. Cancer 2011, 15:2898-2910. Japan HPV And Cervical Cancer Study Group.
15. Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., Ratnam S., Coutlée F., Franco E.L. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N. Engl. J. Med. 2007, 357:1579-1588. Canadian Cervical Cancer Screening Trial Study Group.
16. Molijn A., Kleter B., Quint W., van Doorn L.J. Molecular diagnosis of human papillomavirus (HPV) infection. J. Clin. Virol. 2005, 32(Suppl. 1):S43-S51.
17. Mori S., Nakao S., Kukimoto I., Kusumoto-Matsuo R., Kondo K., Kanda T. Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers. Cancer Sci. 2011, 102:1223-1227.
18. Onuki M., Matsumoto K., Satoh T., Oki A., Okada S., Minaguchi T., Ochi H., Nakao S., Someya K., Yamada N., Hamada H., Yoshikawa H. Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. Cancer Sci. 2009, 100:1312-1316.
19. Saetiew C., Limpaiboon T., Jearanaikoon P., Daduang S., Pientong C., Kerdsin A., Daduang J. Rapid detection of the most common high-risk human papillomaviruses by loop-mediated isothermal amplification. J. Virol. Methods 2011, 178:22-30.
20. Sherman M.E., Lorincz A.T., Scott D.R., Wacholder S., Castle P.E., Glass A.G., Mielzynska-Lohnas I., Rush B.B., Schiffman M. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J. Natl. Cancer Inst. 2003, 95:46-52.
21. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., Raab S., Sherman M., Wilbur D., Wright T., Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. J. Am. Med. Assoc. 2002, 287:2114-2119. Forum Group Members, Bethesda 2001 Workshop.
22. Takahashi M., Okada J., Ito K., Hashimoto M., Hashimoto K., Yoshida Y., Furuichi Y., Ohta Y., Mishiro S., Gemma N. Construction of an electrochemical DNA chip for simultaneous genotyping of single nucleotide polymorphisms. Analyst 2005, 130:687-693.
23. Wheeler C.M., Hunt W.C., Schiffman M., Castle P.E. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J. Infect. Dis. 2006, 194:1291-1299. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group.
24. Wright T.C., Schiffman M., Solomon D., Cox J.T., Garcia F., Goldie S., Hatch K., Noller K.L., Roach N., Runowicz C., Saslow D. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet. Gynecol. 2004, 103:304-309.
25. Yoshikawa H., Kawana T., Kitagawa K., Mizuno M., Yoshikura H., Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn. J. Cancer Res. 1991, 82:524-531.